TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ZYDUS

NeurologyOncologyInfectious Disease
Generics

ZYDUS is a generic drug manufacturer focused on Neurology, Oncology, Infectious Disease. Key products include SERTRALINE HYDROCHLORIDE.

1992
Since
13
Drugs
-
Trials
159
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 35%
2 drugs
Oncology 29%
1 drugs Phase 3: 1
Infectious Disease 18%
0 drugs Phase 2: 3
Gastroenterology 12%
0 drugs Phase 2: 1 Phase 1: 2
Immunology 6%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Oncology, Immunology, Neurology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology